The Patent Finder
US

Methods Of Treating Fabry Patients Having Renal Impairment

US 10,857,141 In force
OverviewFamilyAssignmentsSources & methods
Collateral for a security interest recorded Apr 27, 2026 (Citibank, N.A.).

Term ends May 30, 2038 · Low confidence

Filed Mar 13, 2020 as application 16/817,881 · Granted Dec 8, 2020
Base term, 20 years from filing
Today
20 years from filing
2018 2038
Clock starts
May 30, 2018
Term ends
May 30, 2038
Granted
Dec 8, 2020
base term fee events Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
No effect
Terminal disclaimer
Resolved from the filed document, referencing US 10,251,873, US 10,471,053, US 10,792,278, US 10,792,279, US 10,799,491, US 10,806,727, US 10,849,889, US 10,849,890, US 10,857,142, US 10,874,655, US 10,874,656, US 10,874,657, to May 30, 2038. The term already ends on or before that date, so the cap shortened nothing.
1 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
46
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.

This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. 1 of 3 maintenance fees is paid so far. Confidence: Low. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts May 30, 2018, when application 15/992,336, the earliest non-provisional in its chain, was filed (this one was filed Mar 13, 2020); a parent in its chain could not be resolved (the next row)May 30, 2038High confidence
Continuity chainA parent in the chain could not be resolveddated from this application's own claimMedium confidence
Patent term adjustmentNone on fileno changeHigh confidence
Terminal disclaimer capDisclaimer resolved from the filed document (refs US 10,251,873, US 10,471,053, US 10,792,278, US 10,792,279, US 10,799,491, US 10,806,727, US 10,849,889, US 10,849,890, US 10,857,142, US 10,874,655, US 10,874,656, US 10,874,657)resolves to May 30, 2038, no earlier than this term, so no changeHigh confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events1 of 3 maintenance fees paidIn forceHigh confidence
Further caveats on recordThe record names parents not resolved: 16678183Low confidence overallLow confidence
Computed term endThe steps above, in orderMay 30, 2038Low confidence

This family

US 10,251,873In force
May 2038
May 2038
US 10,471,053In force
May 2038
May 2038
US 10,874,655In force
May 2038
May 2038
US 10,849,889In force
May 2038
May 2038
US 10,857,141this patent
May 2038
May 2038
US 10,874,656In force
May 2038
May 2038
US 10,874,657In force
May 2038
May 2038
US 10,857,142In force
May 2038
May 2038
8 of 46 applications in this family shown, earliest filings first. Every application listed has its file history here. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
May 11, 2020
Reel 52625, frame 916
Amicus Therapeutics, Inc.Biopharma Credit PLCSecurity Interest
May 21, 2020
Reel 52741, frame 173
Biopharma Credit PLCBPCR Limited PartnershipOmnibus Confirmation of Assignment Agreement
Jul 30, 2020
Reel 53360, frame 659
BPCR Limited PartnershipAmicus Therapeutics, Inc.Release of Security Interest
Jul 30, 2020
Reel 53365, frame 342
Amicus Therapeutics, Inc.Hayfin Services LLP, as AgentSecurity Interest
Aug 5, 2022
Reel 61099, frame 803
Castelli, Jeff; Benjamin, ElfridaAmicus Therapeutics, Inc.Assignment of Assignor's Interest
Oct 6, 2023
Reel 65177, frame 196
Amicus Therapeutics, Inc.Wilmington Trust, National AssociationSecurity Interest
Oct 6, 2023
Reel 65164, frame 945
Hayfin Services LLPAmicus Therapeutics, Inc.Release of Security Interest
Apr 27, 2026
Reel 75493, frame 968
Biomarin Pharmaceutical Inc.; Amicus Therapeutics, Inc.Citibank, N.A., as Collateral AgentSecurity Interest
Apr 27, 2026
Reel 75494, frame 30
Wilmington Trust, National AssociationAmicus Therapeutics, Inc.Release of Security Interest

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited